...
【24h】

Pelvic exenteration and sphincter preservation in the treatment of soft tissue sarcomas.

机译:治疗软组织肉瘤时盆腔引流和括约肌保存。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Pelvic sarcomas are rare and there are very few effective therapeutic alternatives. A complete resection is considered the main factor associated to a good prognosis, which justifies the employment of a pelvic exenteration (PE) in selected cases. METHODS: Between 1980 and 2000, 96 PE were performed, nine of which were for sarcomas. The clinical characteristics, surgical and anatomopathological aspects and the patients' evolution were described. RESULTS: The median follow-up time was 24 months (ranging from 1 to 57 months). In relation to the sphincters preservation, at least one sphincter was preserved in five patients. There were two post-operative deaths. In the last follow-up, six patients were alive without any evidence of the disease. CONCLUSION: Pelvic exenterations should be performed for the treatment of selected cases of locally advanced pelvic sarcomas. Sphincter preservation may be performed, provided that oncological resection principles are obeyed.
机译:背景:骨盆肉瘤很少见,几乎没有有效的治疗选择。完全切除被认为是与良好预后相关的主要因素,这证明在某些情况下采用盆腔穿刺术(PE)是合理的。方法:从1980年到2000年,共进行了96次体育运动,其中有9次用于肉瘤。描述了临床特征,手术和解剖病理学方面以及患者的演变。结果:中位随访时间为24个月(1到57个月不等)。关于括约肌的保存,五名患者中至少保留了一个括约肌。术后有两人死亡。在最后一次随访中,有6名患者活着,没有任何疾病迹象。结论:应行盆腔穿刺术治疗局部晚期盆腔肉瘤。只要遵守肿瘤切除原则,就可以进行括约肌保护。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号